EN
登录

人工智能平台Elea获得430万美元种子轮融资,增强医疗保健专业人员提供挽救生命的诊断和护理的能力

elea Raises $4.3M AI-Powered Pathology Operating System

HIT 等信源发布 2025-03-12 13:46

可切换为仅中文


What You Should Know:

你应该知道的:

elea

埃莱亚

, an innovative

,一种创新的

AI platform

人工智能平台

designed to supercharge healthcare professionals’ ability to deliver life-saving diagnoses and care, has announced a $4.3M (€4M)funding round led by

旨在增强医疗保健专业人员提供挽救生命诊断和护理的能力,已宣布由领投的 430 万美元(400 万欧元)融资回合。

Fly Ventures

飞风险投资

and

Giant Ventures

巨无霸创投

.

– The company has also secured a milestone partnership with one of Germany’s largest and most critical Medizinische Versorgungszentrum (MVZ) hospital groups.

– 该公司还与德国最大且最重要的医疗供应中心 (MVZ) 医院集团之一达成了里程碑式的合作伙伴关系。

Addressing the Healthcare Crisis with AI

利用人工智能应对医疗危机

elea was founded to address the growing crises plaguing global healthcare systems, including staff shortages, physician burnout (affecting 28% of doctors), rising demand, increasing cancer rates, aging populations, and administrative overload. The platform acts as an “always on-hand” AI operating system, functioning as a true AI agent rather than a mere workflow tool..

elea 的成立旨在应对困扰全球医疗保健系统的日益严重的危机,包括人员短缺、医生职业倦怠(影响 28% 的医生)、需求上升、癌症发病率增加、人口老龄化以及行政负担过重等问题。该平台充当“始终在手”的人工智能操作系统,作为真正的人工智能代理,而不仅仅是工作流程工具。

By deeply integrating with the numerous systems healthcare professionals rely on, and optimized for mobile use, elea leverages voice recognition and conversational AI to respond to clinicians’ needs. It autonomously navigates between systems, adapts to commands, and anticipates tasks—from drafting diagnoses to generating reports—with speed, context, and accuracy, effectively addressing falling productivity..

通过与医疗专业人员所依赖的众多系统深度融合,并针对移动使用进行优化,elea 利用语音识别和对话式人工智能来响应临床医生的需求。它能够自主在系统间导航,适应指令,预测任务——从起草诊断到生成报告——以速度、上下文和准确性有效应对生产力下降的问题。

Currently, healthcare professionals spend 40% of their time on administrative tasks, compared to 30% on patient care. elea aims to shift this balance, freeing clinicians to focus on what matters most: their patients.

目前,医疗专业人员将40%的时间花在行政任务上,而只有30%的时间用于患者护理。elea旨在改变这种平衡,让临床医生能够专注于最重要的事情:他们的患者。

A World-Class Team and Early Momentum

世界一流的团队和早期动能

elea is the culmination of over a decade of expertise from a team intimately familiar with healthcare’s challenges and the transformative power of AI. Dr. Christoph Schröder (CEO) led early AI and autonomous driving projects at Luminar, Mercedes, and Bosch, while Dr. Sebastian Casu (CMO) brings over a decade of experience in intensive care, anesthesiology, and emergency departments.

elea 是一支对医疗保健领域的挑战和人工智能变革力量有着深刻理解的团队十多年经验的结晶。克里斯托夫·施罗德博士(首席执行官)曾在 Luminar、梅赛德斯和博世领导早期的人工智能和自动驾驶项目,而塞巴斯蒂安·卡苏博士(首席营销官)则拥有十多年的重症监护、麻醉学和急诊科经验。

They are joined by co-founders Tobias Lygren and Stephan Frank, along with world-class engineering and healthcare teams in Hamburg and Mountain View..

他们与联合创始人托比亚斯·莱格伦和斯特凡·弗兰克以及汉堡和山景城的世界级工程和医疗团队一起加入。

Despite launching in 2024, elea’s AI-first operating system is already transforming pathology labs across Germany through its partnership with a major MVZ hospital group. Previously, testing and diagnosis could take 2-3 weeks; elea has reduced this to just hours. Reports can now be validated by clinicians and issued to patients with a single click, enabling immediate life-saving interventions and treatments.

尽管 elea 的 AI 首先操作系统在 2024 年才推出,但通过与一家主要的 MVZ 医院集团合作,它已经在德国各地的病理实验室中实现了变革。以前,测试和诊断可能需要 2-3 周的时间;而 elea 已将其缩短到仅仅几个小时。现在,临床医生可以通过单击验证报告并将其发布给患者,从而实现即时的挽救生命干预和治疗。

With the MVZ group processing an exceptionally large number of cases annually, the impact is set to scale significantly..

随着MVZ集团每年处理的案件数量异常庞大,其影响势必显著扩大。

Scaling Department by Department

逐部门扩展

To maximize the platform’s impact, elea is adopting a department-by-department approach to scaling, starting with pathology. The new funding will be used to continue scaling this approach and expand into new departments.

为了最大化平台的影响,elea 正在采用逐部门扩展的方法,首先从病理学开始。新的资金将用于继续扩展这种方法,并进入新的部门。

“No-one joins the healthcare sector to spend hours on admin; we’re driven by our desire to help people. Yet today’s systems, even the add-on solutions that promise to help, fall short. Clinicians’ hands remain tied and our patients miss out. With Elea, we’re proving technology can be an ally, not an obstacle, and can finally bring the power of this technology to achieve better patient outcomes and, ultimately, save lives,” said Dr Sebastian Casu, co-founder and CMO of elea..

“没有人加入医疗行业是为了花数小时处理行政事务;我们的动力来自于帮助他人的渴望。然而,当今的系统,甚至是那些承诺提供帮助的附加解决方案,都未能达到预期。临床医生的手脚依然被束缚,我们的患者也得不到应有的服务。通过Elea,我们正在证明技术可以成为盟友,而不是障碍,并最终能够发挥这项技术的力量,实现更好的患者疗效,最终挽救生命,”elea联合创始人兼首席营销官塞巴斯蒂安·卡苏博士说道。